Metraipolis › archive › dc_8eb0f0469732
Reassessing Mandatory Folic Acid Fortification for Neural Tube Defect Prevention: Evidence, Uncertainty, and Policy Implications — Europe PMC PMID:42280401
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42280401
- DOI
- 10.3390/nu18111758
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-01T03:10:49.645Z
- SHA-256 of the archived text
47b6fad15f34fe98a8a82f58a533a821fa28e1695c68cec225bb1d6ffe51222d- Stable URL of this page
https://metraipolis.com/documento/dc_8eb0f0469732
How to cite
Reassessing Mandatory Folic Acid Fortification for Neural Tube Defect Prevention: Evidence, Uncertainty, and Policy Implications — Europe PMC PMID:42280401 — Europe PMC (en), https://europepmc.org/article/MED/42280401 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_8eb0f0469732 (Metraipolis archive dc_8eb0f0469732, sha256 47b6fad15f34fe98a8a82f58a533a821fa28e1695c68cec225bb1d6ffe51222d)
BibTeX
@misc{dc8eb0f0469732,
title = {Reassessing Mandatory Folic Acid Fortification for Neural Tube Defect Prevention: Evidence, Uncertainty, and Policy Implications — Europe PMC PMID:42280401},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42280401},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_8eb0f0469732; sha256 47b6fad15f34fe98a8a82f58a533a821fa28e1695c68cec225bb1d6ffe51222d},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42280401. Agents can read the archived copy with the MCP tool read_document.